参考文献/References:
[1]张宏,张浩,刘丽,等.《2018年美国肝病学会肝细胞癌治疗指南》摘译[J].临床肝胆病杂志,2018,34(4):743-748. [2]《原发性肝癌诊疗规范(年版)》编写专家委员会.原发性肝癌诊疗规范(2019年版)[J].中国临床医学,2020,27(1):140-156. [3]钟赣生.中药学供中医学、针灸推拿学、中西医临床医学、中药学等专业用[M].第十版.北京:中国中医药出版社,2016. [4]Huang Y,Liu C,Zeng WC,et al.Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway[J].Bioscience Reports,2020,40(1):BSR20192727. [5]Qie S,Diehl JA.Cyclin D1,cancer progression,and opportunities in cancer treatment[J].Journal of Molecular Medicine,2016,94(12):1-14. [6]Leu YL,Wang TH,Wu CC,et al.Hydroxygenkwanin Suppresses Non-Small Cell Lung Cancer Progression by Enhancing EGFR Degradation[J].Molecules,2020,25(4):941. [7]Huang YC,Lee PC,Wang JJ,et al.Anticancer Effect and Mechanism of Hydroxygenkwanin in Oral Squamous Cell Carcinoma[J].Frontiers in Oncology,2019(9):911. [8]Chou LF,Chen CY,Yang WH,et al.Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression[J].Biomolecules,2019,10(1):20. [9]Bella L,Zona S,Gabriela N,et al.FOXM1:A key oncofoetal transcription factor in health and disease[J].Seminars in Cancer Biology,2014(29):32-39. [10]Zona S,Bella L,Burton M J,et al.FOXM1:An emerging master regulator of DNA damage response and genotoxic agent resistance[J].Biochimica et Biophysica Acta(BBA)- Gene Regulatory Mechanisms,2014,1839(11):1316-1322. [11]Gartel AL.FOXM1 in Cancer:Interactions and Vulnerabilities[J].Cancer Research,2017,77(12):3135-3139. [12]Ke M,Zhang Z,Xu B,et al.Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells[J].International Immunopharmacology,2019(75):105824. [13]Zhang J,Dang F,Ren J,et al.Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy[J].Trends in Biochemical Sciences,2018,43(12):1014-1032. [14]Chen G,Huang AC,Wei Z,et al.Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response[J].Nature,2018,560(7718):382-386. [15]Mandai M,Hamanishi J,Abiko K,et al.Dual Faces of IFN in Cancer Progression:A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity[J].Clinical Cancer Research,2016,22(10):2329-2334. [16]Garcia-Diaz A,Shin DS,Moreno BH,et al.Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression[J].Cell Reports,2017,19(6):1189. [17]Jiang X,Zhou J,Giobbie-Hurder A,et al.The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition[J].Clinical Cancer Research,2013,19(3):598-609. [18]Qin Y,Liu H J,Li M,et al.Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway[J].E Bio Medicine,2018(38):25-36. [19]Fischer KR,Durrans A,Lee S,et al.Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance[J].Nature,2015,527(7579):472-476. [20]Joseph JP,Mk H,Pillai AA,et al.Hypoxia induced EMT:A review on the mechanism of tumor progression and metastasis in OSCC[J].Oral Oncology,2018(80):23-32. [21]Sun DP,Li XX,Liu XL,et al.Gypenosides Induce Apoptosis by Ca2+ Overload Mediated by Endoplasmic-Reticulum and Store-Operated Ca2+ Channels in Human Hepatoma Cells[J].Cancer Biotherapy&Radiopharmaceuticals,2013,28(4):320-326. [22]Wang QF,Chen JC,Hsieh SJ,et al.Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells[J].Cancer Letters,2002,183(2):169-178. [23]Zheng K,Liao C,Li Y,et al.Gypenoside L,Isolated from Gynostemma pentaphyllum,Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells through Reactive-Oxygen-Species-Mediated Unfolded Protein Response[J].Journal of Agricultural&Food Chemistry,2016,64(8):1702. [24]Chen K,Zhu P,Ye J,et al.Oxymatrine inhibits the migration and invasion of hepatocellular carcinoma cells by reducing the activity of MMP-2/-9 via regulating p38 signaling pathway[J].Journal of Cancer,2019,10(22):5397-5403. [25]Song J,Zhang X,Ge Q,et al.CRISPR/Cas9﹎ediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells[J].Journal of Cellular Biochemistry,2018,119(10):8419-8431. [26]Chen J,Xiao X,Qi L,et al.Role of Pittsburgh Modified TNM Criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma[J].Chinese Medical Journal,2007,120(24):2200-2203. [27]Gialeli C,Theocharis AD,Karamanos NK.Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting[J].FEBS Journal,2011,278(1):16-27. [28]Zhang Q,Chen W,Lv X,et al.Piperlongumine,a Novel TrxR1 Inhibitor,Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress[J].Frontiers in Pharmacology,2019(10):1180. [29]Kapoor S.Tumor growth attenuating effect of celastrol in systemic malignancies[J].Journal International Du Cancer,2016,139(6):1431. [30]Vliet A,Garg A D,Agostinis P.Coordination of stress,Ca2+,and immunogenic signaling pathways by PERK at the endoplasmic reticulum[J].Biological Chemistry,2016,397(7):649-656. [31]Schleicher SM,Moretti L,Varki V,et al.Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer:implications for future therapeutic approaches[J].Drug Resist Updat,2010,13(3):79-86. [32]Bo R,Hui L,Hang G,et al.Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR[J].Oncotarget,2017,8(54):93039-93050. [33]Shao S,Duan W,Xu Q,et al.Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF[J].Oxidative Medicine&Cellular Longevity,2019(2019):8148510. [34]Lucas J,Hsieh TC,Halicka HD,et al.Upregulation of PD?L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFκB signaling[J].International Journal of Oncology,2018,53(4):1469-1480. [35]Zhang B,Yin X,Sui S.Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide3kinase/protein kinaseB pathway[J].Oncology Reports,2018,40(5):2758-2765. [36]Huang WH,Liao WR,Sun RX.Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1[J].International Journal of Molecular Medicine,2016,38(2):551-557. [37]Yoshida R,Nagata M,Nakayama H,et al.The pathological significance of Notch1 in oral squamous cell carcinoma[J].Laboratory Investigation,2013,93(10):1068-1081. [38]Wang F,Hou W,Chitsike L,et al.ABL1,Overexpressed in Hepatocellular Carcinomas,Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice[J].Gastroenterology,2020,159(1):289-305,e16. [39]Zhu MS,Xu LB,Hong Z,et al.Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines[J].International Journal of Clinical And Experimental Pathology,2014,7(9):5782-5791.
相似文献/References:
[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及
肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Medical Information,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]李珊珊,陈少彬,龚先琼.中药单体治疗非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(21):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
LI Shan-shan,CHEN Shao-bin,GONG Xian-qiong.Advances in Research of Traditional Chinese Medicine Monomer in the Treatment of
Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(09):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
[3]林思萍,龚先琼.中药单体调控TGF-β1/Smads信号通路抗纤维化的研究[J].医学信息,2019,32(21):30.[doi:10.3969/j.issn.1006-1959.2019.21.011]
LIN Si-ping,GONG Xian-qiong.Study on Anti-Fibrosis of TGF-β1/Smads Signaling Pathway Regulated by Chinese Medicine Monomer[J].Medical Information,2019,32(09):30.[doi:10.3969/j.issn.1006-1959.2019.21.011]
[4]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Medical Information,2019,32(09):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[5]钟小丽,龚先琼.基于JAK2/STAT3信号通路探讨中药单体治疗肝癌的研究[J].医学信息,2020,33(01):21.[doi:10.3969/j.issn.1006-1959.2020.01.009]
ZHONG Xiao-li,GONG Xian-qiong.Study on the Treatment of Liver Cancer with Traditional Chinese Medicine Monomer Based on JAK2/STAT3 Signaling Pathway[J].Medical Information,2020,33(09):21.[doi:10.3969/j.issn.1006-1959.2020.01.009]
[6]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Medical Information,2022,35(09):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
[7]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Medical Information,2022,35(09):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
[8]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Medical Information,2020,33(09):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
[9]林芳芳,龚先琼.中药单体治疗酒精性肝损伤的研究现状[J].医学信息,2021,34(05):32.[doi:10.3969/j.issn.1006-1959.2021.05.010]
LIN Fang-fang,GONG Xian-qiong.Advances in the Treatment of Alcoholic Liver Injury by Monomer of Traditional Chinese Medicine[J].Medical Information,2021,34(09):32.[doi:10.3969/j.issn.1006-1959.2021.05.010]
[10]裴金仙,陈天狮,任巧晶,等.JAK2/STAT3通路在HBV相关肝细胞癌中表达及机制研究[J].医学信息,2022,35(24):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Expression and Mechanism of JAK2/STAT3 Pathway in HBV-related Hepatocellular Carcinoma[J].Medical Information,2022,35(09):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]